Efficacy and safety results of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

被引：0

作者：

Menter, A. ^{[1
]}

Gottlieb, A. ^{[2
]}

Leonardi, C. ^{[3
]}

Kerdel, F. ^{[4
]}

Gu, Y. ^{[5
]}

Valdes, J. ^{[5
]}

机构：

[1] Baylor Res Inst, Dallas, TX USA

[2] Tufts Med Ctr, Boston, MA USA

[3] Cent Dermatol, St Louis, MO USA

[4] Florida Acad Dermatol Ctr, Miami, FL USA

[5] Abbott Labs, Abbott Pk, IL 60064 USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2011年 / 165卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：38 / 39

页数：2

共 50 条

[1] Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
Gottlieb, A. B.
Leonardi, C.
Kerdel, F.
Mehlis, S.
Olds, M.
Williams, D. A.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (03) : 652 - 660
[2] Efficacy and safety results of ABT-874 vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
Menter, A.
Gottlieb, A.
Leonardi, C.
Kerdel, F.
Yoo, S.
Gu, Y.
Valdes, J.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 31 - 32
[3] Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
Strober, B. E.
Crowley, J. J.
Yamauchi, P. S.
Olds, M.
Williams, D. A.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (03) : 661 - 668
[4] Efficacy and safety of briakinumab vs. methotrexate in patients with moderate to severe psoriasis
Reich, K.
Langley, R. G.
Papp, K.
Ortonne, J. -P.
Unnebrink, K.
Kaul, M.
Valdes, J.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 : 4 - 4
[5] ABT-874 versus etanercept and placebo in patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results
Strober, Bruce
Crowley, Jeffrey
Valdes, Joaquin
Gu, Yihua
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB155 - AB155
[6] ABT-874 versus etanercept and placebo in patients with moderate to severe chronic plaque psoriasis: efficacy and safety results
Strober, B.
Crowley, J.
Yamauchi, P.
Yoo, S.
Gu, Y.
Valdes, J.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 10 - 11
[7] Efficacy and safety results of ABT-874 versus etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
Gottlieb, Alice
Leonardi, Craig
Valdes, Joaquin
Gu, Yihua
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB159 - AB159
[8] Efficacy and safety of etanercept in moderate to severe plaque psoriasis
Tunca, M.
Koc, E.
Akar, A.
Kurumlu, Z.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 : 53 - 53
[9] Pooled safety and efficacy results from two phase III trials comparing briakinumab with etanercept and placebo for the treatment of moderate to severe psoriasis
Strober, Bruce
Gottlieb, Alice
Williams, David
Gu, Yihua
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB146 - AB146
[10] Efficacy and safety of briakinumab for treatment of moderate to severe psoriasis in patients previously receiving etanercept: Results from an open-label extension
Strober, Bruce
Leonardi, Craig
Williams, David A.
Olds, Michele
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB191 - AB191

← 1 2 3 4 5 →